Wait...
Search Global Export Import Trade Data
Recent Searches: No Recent Searches

Cadila Healthcare soars over 4% post USFDA drug nod ..


Date: 26-03-2018
Subject: Cadila Healthcare soars over 4% post USFDA drug nod .
Cadila HealthcareBSE 4.68 % climbed over 4 per cent on Monday after the company received final approval from the USFDA to market a drug used to treat chest pain, high blood pressure and heart failure. 

The stock rose 4.20 per cent to hit a high of Rs 385.50 on the BSE. 

In a filing to the exchange, the company said it has got the regulator’s approval to market Metoprolol Succinate Extended release tablets in the strengths of 25 mg, 50 mg, 100 mg and 200 mg 

In a filing to the exchange, the company said it has got the regulator’s approval to market Metoprolol Succinate Extended release tablets in the strengths of 25 mg, 50 mg, 100 mg and 200 mg. 

The company said it will be manufactured at the group’s formulations manufacturing facility at Ahmedabad SEZ. 

Meanwhile, foreign brokerage CLSA has upgraded Cadila Healthcare to ‘buy’ from ‘underperform’ and raised target price to Rs 450 from the earlier Rs 440. 

The brokerage said it is upgrading the stock due to attractive valuations. A strong US pipeline despite a high base, and improving India and EM outlook led by biosimilar and vaccines launches are seen as key potential earnings drivers for Cadila 

Source: economictimes.indiatimes.com

Get Sample Now

Which service(s) are you interested in?
 Export Data
 Import Data
 Both
 Buyers
 Suppliers
 Both
OR
 Exim Help
+


What is New?

Date: 12-04-2024
NOTIFICATION No. 09/2024 – CENTRAL TAX
Seeks to extend the due date for filing of FORM GSTR-1, for the month of March 2024

Date: 10-04-2024
NOTIFICATION No. 08/2024- Central Tax
Seeks to extend the timeline for implementation of Notification No. 04/2024-CT dated 05.01.2024 from 1st April, 2024 to 15th May, 2024

Date: 08-04-2024
Notification No 07/2024 – Central Tax
Seeks to provide waiver of interest for specified registered persons for specified tax periods

Date: 04-04-2024
Notification No. 27/2024 - Customs (N.T.)
Exchange Rate Notification No. 27/2024-Cus (NT) dated 04.04.2024-reg

Date: 26-03-2024
Notification No. 24/2024 - Customs (N.T.)
Exchange Rate Notification No. 24/2024-Cus (NT) dated 26.03.2024-reg

Date: 14-03-2024
NOTIFICATION No. 17/2024-Customs
Seeks to amend notification No. 57/2017-Customs dated 30.06.2017 so as to modify BCD rates on certain smart wearable devices.

Date: 12-03-2024
NOTIFICATION No. 15/2024-Customs
Seeks to amend specific tariff items in Chapter 90 of the 1st schedule of Customs Tariff Act, 1975.

Date: 12-03-2024
NOTIFICATION No. 16/2024-Customs
Seeks to amend Notification No. 50/2017-Customs dated 30.06.2017 so as to change the applicable BCD rate on specified parts of medical X-ray machines.

Date: 07-03-2024
Notification No. 18/2024 - Customs (N.T.)
Exchange Rate Notification No. 18/2024-Cus (NT) dated 07.03.2024-reg

Date: 06-03-2024
Notification No. 13/2024-Customs
Seeks to amend notification No. 50/2017- Customs dated 30.06.2017, in order to reduce the BCD on imports of meat and edible offal, of ducks, frozen, subject to the prescribed conditions, with effect from 07.03.2024.



Exim Guru Copyright © 1999-2024 Exim Guru. All Rights Reserved.
The information presented on the site is believed to be accurate. However, InfodriveIndia takes no legal responsibilities for the validity of the information.
Please read our Terms of Use and Privacy Policy before you use this Export Import Data Directory.

EximGuru.com

C/o InfodriveIndia Pvt Ltd
F-19, Pocket F, Okhla Phase-I
Okhla Industrial Area
New Delhi - 110020, India
Phone : 011 - 40703001